全球分子檢測方法市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計分子診斷市場將從 2025 年的 122.7 億美元成長到 2034 年的 315.7 億美元，2026 年至 2034 年的複合年成長率為 11.07%。

受對先進診斷和檢測技術需求不斷成長的推動，全球分子檢測方法市場正經歷強勁成長。 PCR、定序和雜合反應等分子檢測方法在遺傳疾病和感染疾病的檢測中發揮著至關重要的作用。生物技術和生命科學研究領域投資的不斷增加也顯著促進了市場成長。

成長要素包括感染疾病的蔓延和個人化醫療的日益普及。研究實驗室和機構正在投資建造自動化、高通量分子檢測平台。核酸擴增和定序技術的進步正在提高檢測的準確性和效率。此外，發展中地區醫療基礎設施的擴建也進一步刺激了需求。

隨著分子診斷在精準醫療中扮演越來越重要的角色，其未來前景依然強勁。人工智慧在數據分析的應用將提升檢測結果的解讀準確性。新興市場對檢查室現代化改造的投資將創造更多成長機會。隨著基因研究和疾病早期檢測重要性的日益凸顯，全球分子診斷市場預計將穩定擴張。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球分子方法市場：依技術分類

• 市場分析、洞察與預測
• PCR
• 定序
• 微陣列
• 雜合反應
• 其他

第5章 全球分子方法市場：依應用分類

• 市場分析、洞察與預測
• 臨床診斷
• 研究
• 法醫學
• 環境測試
• 其他

第6章：全球分子方法市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院/診斷檢查室
• 學術研究機構
• 製藥和生物技術公司
• 其他

第7章 全球分子方法市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific Inc
  • Danaher Corporation
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers AG
  • Merck KGaA
  • QIAGEN NV
  • Becton
  • Dickinson And Company
  • Agilent Technologies Inc
  • Illumina Inc
  • Bio-Rad Laboratories Inc
  • PerkinElmer Inc
  • GE HealthCare Technologies Inc
  • BioMAfA（C）Rieux SA
  • Takara Bio Inc

The Molecular Methods Market size is expected to reach USD 31.57 Billion in 2034 from USD 12.27 Billion (2025) growing at a CAGR of 11.07% during 2026-2034.

The Global Molecular Methods Market is experiencing robust growth driven by increasing demand for advanced diagnostic and research techniques. Molecular methods such as PCR, sequencing, and hybridization play a crucial role in detecting genetic disorders and infectious diseases. Rising investments in biotechnology and life sciences research are significantly supporting market expansion.

Major growth drivers include growing prevalence of infectious diseases and increasing adoption of personalized medicine. Laboratories and research institutions are investing in automated and high-throughput molecular testing platforms. Technological advancements in nucleic acid amplification and sequencing technologies are enhancing accuracy and efficiency. Additionally, expanding healthcare infrastructure in developing regions is further boosting demand.

Future prospects remain strong as molecular diagnostics become central to precision healthcare. Integration of artificial intelligence in data analysis will improve test interpretation. Emerging markets investing in laboratory modernization will create additional growth opportunities. As genetic research and early disease detection gain importance, the Global Molecular Methods Market is expected to expand steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• PCR
• Sequencing
• Microarray
• Hybridization
• Others

By Application

• Clinical Diagnostics
• Research
• Forensic
• Environmental Testing
• Others

By End-User

• Hospitals and Diagnostic Laboratories
• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Others

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Danaher Corporation, Abbott Laboratories, F HoffmannLa Roche Ltd, Siemens Healthineers AG, Merck KGaA, QIAGEN NV, Becton, Dickinson and Company, Agilent Technologies Inc, Illumina Inc, BioRad Laboratories Inc, PerkinElmer Inc, GE HealthCare Technologies Inc, bioMrieux SA, Takara Bio Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MOLECULAR METHODS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. PCR Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Microarray Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Hybridization Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MOLECULAR METHODS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Clinical Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Forensic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Environmental Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MOLECULAR METHODS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals and Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Academic and Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Pharmaceutical and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MOLECULAR METHODS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Technology
  • 7.2.2 By Application
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Technology
  • 7.3.2 By Application
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Technology
  • 7.4.2 By Application
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Technology
  • 7.5.2 By Application
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Technology
  • 7.6.2 By Application
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL MOLECULAR METHODS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific Inc
  • 9.2.2 Danaher Corporation
  • 9.2.3 Abbott Laboratories
  • 9.2.4 F. Hoffmann-La Roche Ltd
  • 9.2.5 Siemens Healthineers AG
  • 9.2.6 Merck KGaA
  • 9.2.7 QIAGEN N.V
  • 9.2.8 Becton
  • 9.2.9 Dickinson And Company
  • 9.2.10 Agilent Technologies Inc
  • 9.2.11 Illumina Inc
  • 9.2.12 Bio-Rad Laboratories Inc
  • 9.2.13 PerkinElmer Inc
  • 9.2.14 GE HealthCare Technologies Inc
  • 9.2.15 BioMAfA(C)Rieux SA
  • 9.2.16 Takara Bio Inc